COVAX and the challenges of worldwide vaccine access
Vaccines are showing us a way out of the coronavirus pandemic, but vaccine access is still shockingly inequitable. Over a billion doses have been administered since December 2020, but the vast majority have gone to citizens of high-income countries. The COVAX initiative, a unique collaboration led by the Vaccine Alliance Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO), aims to combat this injustice.
A scientist’s opinion: Interview with Aurélia Nguyen about the Global Alliance for Vaccines and Immunisation (Gavi)
We spoke to Aurélia Nguyen, Managing Director of the COVAX Facility at Gavi. Gavi was founded in response to a market failure: by the late 90s, many powerful vaccines were becoming available, but they were too expensive for low-income countries, and millions of children were unable to benefit from them. In 1997, the Bill and ...
A scientist’s opinion: Interview with Dr Frederik Kristensen about the Coalition for Epidemic Preparedness Innovations (CEPI)
Dr Frederik Kristensen on COVAX: ‘The biggest mass immunisation effort in history’. He has been with the Coalition for Epidemic Preparedness Innovations (CEPI) in Norway since late 2016, initially as Senior Medical Officer, and since January 2018 as Deputy CEO. He started his career as a general practitioner, and before joining CEPI he worked as ...